Dendreon Pharmaceuticals   - Ownership and Business Overview

Life ScienceCompany

Dendreon Pharmaceuticals   Ownership

Who owns Dendreon Pharmaceuticals  ?

Dendreon Pharmaceuticals   is owned by Sanpower Group. It was acquired on January 9, 2017.

Dendreon Pharmaceuticals   Business Overview

Where is Dendreon Pharmaceuticals   headquartered?

Dendreon Pharmaceuticals   is headquartered in Seattle, Washington.

What sector is Dendreon Pharmaceuticals   in?

Dendreon Pharmaceuticals   is a life science company.

When was Dendreon Pharmaceuticals   founded?

Dendreon Pharmaceuticals   was founded in 1992.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Dendreon Pharmaceuticals, Inc.

1301 2nd Avenue,
Seattle, Washington 98101
United States,
(206) 256-4545
www.dendreon.com

Dendreon Pharmaceuticals, Inc. is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients.


 Subscribe to unlock this and 206,427
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.